The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection

Journal of Viral Hepatitis

Volumn 14, Issue 10, 2007, Pages 675-687

  Zeremski, M ^a   Petrovic, L M ^b   Talal, A H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokines; Hepatitis C virus; Inflammation; Viral hepatitis pathogenesis

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON INDUCIBLE T CELL ALPHA CHEMOATRACTANT; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PEGINTERFERON; RANTES; RIBAVIRIN; UNCLASSIFIED DRUG;

CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE COURSE; HEPATITIS C; HUMAN; INFLAMMATORY CELL; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; TH1 CELL; TREATMENT OUTCOME;

ANIMALS; BIOLOGICAL MARKERS; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINE CCL5; CHEMOKINE CXCL10; CHEMOKINE CXCL11; CHEMOKINES; DISEASE PROGRESSION; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION; LIVER; RECEPTORS, CCR5; RECEPTORS, CXCR3; TH1 CELLS;

EID: 34347336666     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2006.00838.x     Document Type: Review

References (103)

1. World Health Organization. Hepatitis C. Fact Sheet No. 164, 2000 Available at: http://www.who.int/mediacentre/factsheets/fs164/en/ ; accessed 31 August 2006.
2. Ghany MG, Kleiner DE, Alter H et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003 124 : 97 104.
3. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001 34 : 730 739.
4. Afdhal NH. The natural history of hepatitis C. Semin Liver Dis 2004 24 (Suppl 2 3 8.
5. Missale G, Bertoni R, Lamonaca V et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996 98 : 706 714.
6. Gerlach JT, Diepolder HM, Jung MC et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999 117 : 933 941.
7. Takaki A, Wiese M, Maertens G et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000 6 : 578 582.
8. Lechner F, Wong DK, Dunbar PR et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000 191 : 1499 1512.
9. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001 194 : 1395 1406.
10. Wertheimer AM, Miner C, Lewinsohn DM, Sasaki AW, Kaufman E, Rosen HR. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 2003 37 : 577 589.
11. Cooper S, Erickson AL, Adams EJ et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999 10 : 439 449.
12. Thimme R, Bukh J, Spangenberg HC et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 2002 99 : 15661 15668.
13. Grakoui A, Shoukry NH, Woollard DJ et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003 302 : 659 662.
14. Dustin LB, Rice CM. Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol, (in press).
15. Dumoulin FL, Bach A, Leifeld L et al. Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J Infect Dis 1997 175 : 681 685.
16. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996 24 : 759 765.
17. Sobue S, Nomura T, Ishikawa T et al. Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection. J Gastroenterol 2001 36 : 544 551.
18. Bertoletti A, Maini MK. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection Curr Opin Immunol 2000 12 : 403 408.
19. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999 30 : 595 601.
20. Fontaine H, Nalpas B, Poulet B et al. Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C. Hum Pathol 2001 32 : 904 909.
21. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996 24 : 289 293.
22. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000 95 : 3032 3043.
23. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000 12 : 121 127.
24. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000 18 : 217 242.
25. Murphy PM, Baggiolini M, Charo IF et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000 52 : 145 176.
26. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998 338 : 436 445.
27. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998 187 : 129 134.
28. Loetscher P, Uguccioni M, Bordoli L et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998 391 : 344 345.
29. Qin S, Rottman JB, Myers P et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998 101 : 746 754.
30. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994 76 : 301 314.
31. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996 272 : 60 66.
32. Klugewitz K, Adams DH, Emoto M, Eulenburg K, Hamann A. The composition of intrahepatic lymphocytes: shaped by selective recruitment Trends Immunol 2004 25 : 590 594.
33. Lalor PF, Adams DH. The liver: a model of organ specific lymphocyte recruitment. Expert Rev Mol Med 2002 4 : 1 15.
34. Liu L, Kubes P. Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action. Thromb Haemost 2003 89 : 213 220.
35. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 1999 163 : 6236 6243.
36. Apolinario A, Majano PL, Alvarez-Perez E et al. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol 2002 97 : 2861 2870.
37. Harvey CE, Post JJ, Palladinetti P et al. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol 2003 74 : 360 369.
38. Luster AD, Unkeless JC, Ravetch JV. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985 315 : 672 676.
39. Neville LF, Mathiak G, Bagasra O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev 1997 8 : 207 219.
40. Amichay D, Gazzinelli RT, Karupiah G, Moench TR, Sher A, Farber JM. Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo. J Immunol 1996 157 : 4511 4520.
41. Ishiguro N, Takada A, Yoshioka M et al. Induction of interferon-inducible protein-10 and monokine induced by interferon-gamma from human endothelial cells infected with Influenza A virus. Arch Virol 2004 149 : 17 34.
42. Narumi S, Yoneyama H, Inadera H et al. TNF-alpha is a potent inducer for IFN-inducible protein-10 in hepatocytes and unaffected by GM-CSF in vivo, in contrast to IL-1beta and IFN-gamma. Cytokine 2000 12 : 1007 1016.
43. Matikainen S, Pirhonen J, Miettinen M et al. Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology 2000 276 : 138 147.
44. Nazar AS, Cheng G, Shin HS et al. Induction of IP-10 chemokine promoter by measles virus: comparison with interferon-gamma shows the use of the same response element but with differential DNA-protein binding profiles. J Neuroimmunol 1997 77 : 116 127.
45. Borgland SL, Bowen GP, Wong NC, Libermann TA, Muruve DA. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB. J Virol 2000 74 : 3941 3947.
46. Narumi S, Tominaga Y, Tamaru M et al. Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol 1997 158 : 5536 5544.
47. Nishioji K, Okanoue T, Itoh Y et al. Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes. Clin Exp Immunol 2001 123 : 271 279.
48. Apolinario A, Diago M, Lo Iacono O et al. Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy. Aliment Pharmacol Ther 2004 19 : 551 562.
49. Butera D, Marukian S, Iwamaye AE et al. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood 2005 106 : 1175 1182.
50. Bieche I, Asselah T, Laurendeau I et al. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 2005 332 : 130 144.
51. Romero AI, Lagging M, Westin J et al. Interferon (IFN)- gamma -Inducible Protein-10: Association with Histological Results, Viral Kinetics, and Outcome during Treatment with Pegylated IFN- alpha 2a and Ribavirin for Chronic Hepatitis C Virus Infection. J Infect Dis 2006 194 : 895 903.
52. Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001 358 : 958 965.
53. Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002 347 : 975 982.
54. Itoh Y, Morita A, Nishioji K et al. Clinical significance of elevated serum interferon- inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels. J Viral Hepat 2001 8 : 341 348.
55. Diago M, Castellano G, Garcia-Samaniego J et al. Association of pretreatment serum interferonγ inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 2006 55 : 374 379.
56. Farber JM. A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci U S A 1990 87 : 5238 5242.
57. Farber JM. HuMig: a new human member of the chemokine family of cytokines. Biochem Biophys Res Commun 1993 192 : 223 230.
58. Stylianou E, Yndestad A, Sikkeland LI et al. Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients. Clin Exp Immunol 2002 130 : 279 285.
59. Mahalingam S, Chaudhri G, Tan CL, John A, Foster PS, Karupiah G. Transcription of the interferon gamma (IFN-gamma)-inducible chemokine Mig in IFN-gamma-deficient mice. J Biol Chem 2001 276 : 7568 7574.
60. Cole KE, Strick CA, Paradis TJ et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 1998 187 : 2009 2021.
61. Laich A, Meyer M, Werner ER, Werner-Felmayer G. Structure and expression of the human small cytokine B subfamily member 11 (SCYB11/formerly SCYB9B, alias I-TAC) gene cloned from IFN-gamma-treated human monocytes (THP-1). J Interferon Cytokine Res 1999 19 : 505 513.
62. Clark-Lewis I, Mattioli I, Gong JH, Loetscher P. Structure-function relationship between the human chemokine receptor CXCR3 and its ligands. J Biol Chem 2003 278 : 289 295.
63. Helbig KJ, Ruszkiewicz A, Semendric L, Harley HA, McColl SR, Beard MR. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology 2004 39 : 1220 1229.
64. Helbig KJ, George J, Beard MR. A novel I-TAC promoter polymorphic variant is functional in the presence of replicating HCV in vitro. J Clin Virol 2005 32 : 137 143.
65. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991 3 : 165 183.
66. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990 347 : 669 671.
67. Schall TJ, Jongstra J, Dyer BJ et al. A human T cell-specific molecule is a member of a new gene family. J Immunol 1988 141 : 1018 1025.
68. Moriuchi H, Moriuchi M, Fauci AS. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 1997 158 : 3483 3491.
69. Hashimoto S, Gon Y, Asai Y et al. p38 MAP kinase regulates RANTES production by TNF-alpha-stimulated human pulmonary vascular endothelial cells. Allergy 1999 54 : 1168 1172.
70. Lin YL, Liu CC, Chuang JI et al. Involvement of oxidative stress, NF-IL-6, and RANTES expression in dengue-2-virus-infected human liver cells. Virology 2000 276 : 114 126.
71. Matsukura S, Kokubu F, Kubo H et al. Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am J Respir Cell Mol Biol 1998 18 : 255 264.
72. Soo HM, Garzino-Demo A, Hong W et al. Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES. Virology 2002 303 : 253 277.
73. Thomas LH, Friedland JS, Sharland M, Becker S. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha. J Immunol 1998 161 : 1007 1016.
74. Kusano F, Tanaka Y, Marumo F, Sato C. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab Invest 2000 80 : 415 422.
75. Leifeld L, Dumoulin FL, Purr I et al. Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol 2003 199 : 335 344.
76. Leroy V, Vigan I, Mosnier JF et al. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 2003 38 : 829 841.
77. Nischalke HD, Nattermann J, Fischer HP, Sauerbruch T, Spengler U, Dumoulin FL. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C. Mediators Inflamm 2004 13 : 357 359.
78. Nattermann J, Nischalke HD, Feldmann G Ahlenstiel G, Sauerbruch T, Spengler U. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5. J Viral Hepat 2004 11 : 519 526.
79. Solari R, Offord RE, Remy S et al. Receptor-mediated endocytosis of CC-chemokines. J Biol Chem 1997 272 : 9617 9620.
80. Lichterfeld M, Leifeld L, Nischalke HD et al. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection. J Infect Dis 2002 185 : 1803 1807.
81. Hellier S, Frodsham AJ, Hennig BJ et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 2003 38 : 1468 1476.
82. Promrat K, McDermott DH, Gonzalez CM et al. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 2003 124 : 352 360.
83. Wald O, Pappo O, Ari ZB et al. The CCR5Delta32 allele is associated with reduced liver inflammation in hepatitis C virus infection. Eur J Immunogenet 2004 31 : 249 252.
84. Irving SG, Zipfel PF, Balke J et al. Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q. Nucleic Acids Res 1990 18 : 3261 3270.
85. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002 13 : 455 481.
86. Proost P, Menten P, Struyf S, Schutyser E, De Meester I, Van Damme J. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist. Blood 2000 96 : 1674 1680.
87. Guan E, Wang J, Roderiquez G, Norcross MA. Natural truncation of the chemokine MIP-1 beta /CCL4 affects receptor specificity but not anti-HIV-1 activity. J Biol Chem 2002 277 : 32348 32352.
88. Lukacs NW, Kunkel SL, Allen R et al. Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations. Am J Physiol 1995 268 : L856 L861.
89. McManus CM, Brosnan CF, Berman JW. Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia. J Immunol 1998 160 : 1449 1455.
90. Olszewska-Pazdrak B, Casola A, Saito T et al. Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 1998 72 : 4756 4764.
91. Yang SK, Eckmann L, Panja A, Kagnoff MF. Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 1997 113 : 1214 1223.
92. Bug G, Aman MJ, Tretter T, Huber C, Peschel C. Induction of macrophage-inflammatory protein 1 alpha (MIP-1alpha) by interferon-alpha. Exp Hematol 1998 26 : 117 123.
93. Schwarz M, Radeke HH, Resch K, Uciechowski P. Lymphocyte-derived cytokines induce sequential expression of monocyte- and T cell-specific chemokines in human mesangial cells. Kidney Int 1997 52 : 1521 1531.
94. Miyamoto Y, Kim SU. Cytokine-induced production of macrophage inflammatory protein-1alpha (MIP-1alpha) in cultured human astrocytes. J Neurosci Res 1999 55 : 245 251.
95. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 1993 260 : 355 358.
96. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 1993 177 : 1821 1826.
97. Taub DD, Sayers TJ, Carter CR, Ortaldo JR. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995 155 : 3877 3888.
98. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J Immunol 1995 25 : 64 68.
99. Lin CL, Suri RM, Rahdon RA, Austyn JM, Roake JA. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur J Immunol 1998 28 : 4114 4122.
100. Lanford RE, Guerra B, Chavez D et al. Cross-genotype immunity to hepatitis C virus. J Virol 2004 78 : 1575 1581.
101. Major ME, Dahari H, Mihalik K et al. Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees. Hepatology 2004 39 : 1709 1720.
102. Glass WG, Chen BP, Liu MT, Lane TE. Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease. Viral Immunol 2002 15 : 261 272.
103. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol 2003 38 (Suppl 1 S38 S53.